FDA

U.S. Health Secretary Robert F. Kennedy Jr. has championed “medical freedom” while simultaneously limiting access to COVID-19 vaccines and restricting food stamp purchases, creating what public health experts call a dichotomy in his approach to healthcare policy. What Happened: Kennedy...

A new study has warned that declining childhood vaccination rates in the United States could trigger a dramatic resurgence of diseases that were eradicated years ago. What Happened: On Sunday, former U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb shared a study on X...

The U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced that the Centers for Disease Control and Prevention will no longer recommend COVID-19 vaccines for healthy children and pregnant women, sparking criticism from public health experts who cite ongoing risks. What Happened:...

The U.S. Food and Drug Administration (FDA) approved Eton Pharmaceuticals, Inc.’s (NASDAQ:ETON) new drug application (NDA) for Khindivi (hydrocortisone) oral solution as a replacement therapy for pediatric patients five years of age and older with adrenocortical insufficiency. Adrenocortical...

The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter clinical trial requirements for healthy adults. What Happened: The FDA will now require new...

U.S. Health Secretary Robert Kennedy Jr. praised the Food and Drug Administration’s decision to begin removing fluoride supplements for children from the market, calling the move “long overdue.” What Happened: The FDA announced on Tuesday that it’s initiating a process to...

President Donald Trump signed an executive order Monday directing the Food and Drug Administration to accelerate approvals for domestic pharmaceutical manufacturing facilities as his administration prepares to announce new tariffs on imported medicines within two weeks. What Happened: The executive...

Elon Musk announced plans to make Neuralink‘s brain-computer interface technology “widely available” following the company’s receipt of Breakthrough Device Designation from the Food and Drug Administration for restoring communication in severely speech-impaired individuals....

The President Donald Trump administration’s request for Novavax Inc. (NASDAQ:NVAX) to conduct new clinical trials for its COVID-19 vaccine. What Happened: Novavax announced Monday that the Food and Drug Administration requested a new clinical trial before granting full approval for its...

Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing requirements. What Happened: The FDA on Thursday announced plans to replace animal testing in...

The Centers for Medicare & Medicaid Services has reportedly eliminated jobs in multiple key divisions, including its Office of Minority Health, as part of a sweeping restructuring effort led by Health and Human Services Secretary Robert F. Kennedy Jr. During a virtual all-hands meeting on...

Peter Marks, the U.S. Food and Drug Administration’s top vaccine official, has resigned, citing concerns over Health and Human Services Secretary Robert F. Kennedy Jr.‘s promotion of vaccine misinformation. Marks, a key figure in the development and distribution of COVID-19 vaccines...

On Tuesday, the U.S. Food and Drug Administration revealed results of new agency testing of over 90 acne products containing benzoyl peroxide for possible benzene contamination. More than 90% of tested products had undetectable or extremely low levels of benzene. As a result, the FDA...

On Monday, Glaukos Corporation (NYSE:GKOS) received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) acknowledging the previously submitted New Drug Application (NDA) for Epioxa (Epi-on), its next-gen corneal cross-linking iLink therapy for keratoconus, a...

Several U.S. Food and Drug Administration (FDA) employees involved in the review of Tesla (NASDAQ:TSLA) Chief, Elon Musk‘s private brain implant company, Neuralink, were reportedly dismissed over the weekend. What Happened: The cuts reportedly affected about 20 individuals from the FDA’...